Your session is about to expire
← Back to Search
Electromagnetic Therapy
Pulsed Shortwave Treatment for Postoperative Pain
N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult patients of at least 18 years of age undergoing cholecystectomy
Adult patients of at least 18 years of age undergoing primary knee arthroplasty
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intraoperative (within the operating room)
Awards & highlights
Study Summary
This trial studies using pulsed electromagnetic energy to reduce pain and inflammation, improve healing, and potentially reduce opioid requirements.
Who is the study for?
This trial is for adults over 18 who are having knee or hip replacement surgery, or gallbladder removal. It's not for those with nerve problems in the surgical area, using a pacemaker, pregnant, in jail, or regularly taking opioids/tramadol recently.Check my eligibility
What is being tested?
The study tests if pulsed shortwave therapy can help manage pain after surgery. Participants will receive either the active treatment or a sham (fake) version to compare effectiveness without opioid limitations.See study design
What are the potential side effects?
Pulsed shortwave therapy is generally considered safe but may cause mild skin irritation at the application site. Unlike opioids, it doesn't have systemic side effects like drowsiness or addiction risk.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 or older and scheduled for gallbladder removal surgery.
Select...
I am 18 or older and am having my first knee replacement surgery.
Select...
I am 18 or older and getting my first hip replacement.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ first postoperative week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first postoperative week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pain measured with the Numeric Rating Scale
Secondary outcome measures
AVERAGE pain measured with the Numeric Rating Scale
Awakenings due to pain
Brief pain Inventory, short form (interference subscale)
+13 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active Pulsed Shortwave Treatment with SofPulseActive Control1 Intervention
Application of 8 days of nonthermal, pulsed shortwave (radiofrequency) therapy with Endonovo Therapeutics SofPulse
Group II: Sham TreatmentPlacebo Group1 Intervention
Application of 8 days of sham device
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,337 Total Patients Enrolled
6 Trials studying Postoperative Pain
401 Patients Enrolled for Postoperative Pain
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have muscle or nerve problems in the area where I had surgery.I am 18 or older and scheduled for gallbladder removal surgery.I am 18 or older and am having my first knee replacement surgery.I am 18 or older and getting my first hip replacement.I am scheduled for pain relief medication to be infused near my nerves after surgery.You have a device implanted in your body that sends electrical pulses, like a cardiac pacemaker.Currently in jail or prison.I have been using opioids or tramadol daily for more than 4 weeks.
Research Study Groups:
This trial has the following groups:- Group 1: Active Pulsed Shortwave Treatment with SofPulse
- Group 2: Sham Treatment
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this research effort currently possible?
"This clinical trial, which was initially published on May 1st 2023 and most recently amended on March 31st 2023, is not currently accepting subjects. However, there are 578 other medical trials in the midst of recruitment at this time."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger